Q4229 HCPCS code: Cogenex amniotic membrane, per square centimeter (add-on, list separately in addition to primary procedure)
Q4229 is the HCPCS Level II code for cogenex amniotic membrane, per square centimeter (add-on, list separately in addition to primary procedure). In 2024 Medicare paid an average of $688.87 per service for Q4229 across 62,994 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. Medicare volume rose 444% from 2022 to 2024 (11,587 to 62,994 services). In 2024, about 346 clinicians billed Medicare for Q4229 for 1,947 beneficiaries; Texas, California, Georgia accounted for 43% of services.
Code details
| Field | Value |
|---|---|
| Section | Q codes — Temporary codes |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 11 — Priced using national relative value units (Physician Fee Schedule) |
| BETOS category | O1E — Other drugs |
| Added | 2020-07-01 |
| Last action effective | 2026-01-01 |
Who bills Q4229 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 346 |
| Medicare beneficiaries | 1,947 |
| States with claims | 25 |
| Share of services in top 3 states (Texas, California, Georgia) | 43% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for Q4229, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 11,587 | 313 | $376.93 | $300.37 |
| 2023 | 93,652 | 2,090 | $223.93 | $178.38 |
| 2024 | 62,994 | 1,947 | $864.62 | $688.87 |
States with the most Q4229 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 12,031 | $711.86 |
| California | 9,682 | $599.75 |
| Georgia | 4,747 | $692.52 |
| South Carolina | 3,912 | $702.96 |
| Massachusetts | 3,886 | $684.78 |
What changed for Q4229
- January 2026: Descriptor revised (Was: Cogenex amniotic membrane, per square centimeter)
- 2020-07-01: Q4229 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code Q4229?
Q4229 is the HCPCS Level II code for cogenex amniotic membrane, per square centimeter (add-on, list separately in addition to primary procedure). Short descriptor: "Cogenex amnio memb per sq cm".
How much does Medicare pay for Q4229?
In 2024, the average Medicare payment was $688.87 per service (average allowed $864.62).
Does Medicare cover Q4229?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related Q42 codes
- Q4200 — Skin te, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4201 — Matrion, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4202 — Keroxx (2.5g/cc), 1cc
- Q4203 — Derma-gide, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4204 — Xwrap, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4205 — Membrane graft or membrane wrap, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4206 — Fluid flow or fluid gf, 1 cc
- Q4207 — Carbon life, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4208 — Novafix, per square cenitmeter (add-on, list separately in addition to primary procedure)
- Q4209 — Surgraft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4210 — Axolotl graft or axolotl dualgraft, per square centimeter
- Q4211 — Amnion bio or axobiomembrane, per square centimeter (add-on, list separately in addition to primary procedure)
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under Q4229
- Watch Q4229 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for Q4229
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.